AlphaCrest Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-306,494
| Closed | -$3.18M | – | 575 |
|
|
2022
Q3 | $3.18M | Buy |
306,494
+130,780
| +74% | +$1.35M | 0.19% | 84 |
|
|
2022
Q2 | $2.03M | Buy |
175,714
+143,071
| +438% | +$1.65M | 0.1% | 308 |
|
|
2022
Q1 | $411K | Sell |
32,643
-243,323
| -88% | -$3.06M | 0.02% | 987 |
|
|
2021
Q4 | $3.22M | Buy |
275,966
+136,387
| +98% | +$1.59M | 0.12% | 205 |
|
|
2021
Q3 | $1.82M | Buy |
139,579
+8,834
| +7% | +$115K | 0.09% | 351 |
|
|
2021
Q2 | $1.68M | Buy |
130,745
+17,353
| +15% | +$223K | 0.07% | 424 |
|
|
2021
Q1 | $1.27M | Buy |
113,392
+59,497
| +110% | +$665K | 0.07% | 404 |
|
|
2020
Q4 | $614K | Sell |
53,895
-7,842
| -13% | -$89.3K | 0.05% | 538 |
|
|
2020
Q3 | $555K | Sell |
61,737
-846
| -1% | -$7.61K | 0.06% | 530 |
|
|
2020
Q2 | $646K | Buy |
62,583
+8,095
| +15% | +$83.6K | 0.11% | 281 |
|
|
2020
Q1 | $550K | Buy |
54,488
+43,013
| +375% | +$434K | 0.07% | 524 |
|
|
2019
Q4 | $153K | Sell |
11,475
-12,925
| -53% | -$172K | 0.01% | 1225 |
|
|
2019
Q3 | $209K | Buy |
+24,400
| New | +$209K | 0.01% | 1204 |
|
|
2019
Q2 | – | Sell |
-28,656
| Closed | -$325K | – | 1080 |
|
|
2019
Q1 | $325K | Buy |
+28,656
| New | +$325K | 0.05% | 625 |
|